Mir Hashim
2023
In 2023, Mir Hashim earned a total compensation of $2.2M as Chief Scientific Officer at Rani Therapeutics Holdings, a 7% decrease compared to previous year.
Compensation breakdown
| Option Awards | $996,166 |
|---|---|
| Salary | $416,000 |
| Stock Awards | $756,160 |
| Total | $2,168,326 |
Hashim received $996.2K in option awards, accounting for 46% of the total pay in 2023.
Hashim also received $416K in salary and $756.2K in stock awards.
Rankings
In 2023, Mir Hashim's compensation ranked 480th out of 2,978 executives tracked by ExecPay. In other words, Hashim earned more than 83.9% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 480 out of 2,978 | 84th |
Division Manufacturing | 275 out of 1,637 | 83rd |
Major group Chemicals And Allied Products | 189 out of 906 | 79th |
Industry group Drugs | 186 out of 869 | 79th |
Industry Pharmaceutical Preparations | 117 out of 627 | 81st |
Source: SEC filing on April 17, 2024.
Hashim's colleagues
We found two more compensation records of executives who worked with Mir Hashim at Rani Therapeutics Holdings in 2023.